Four Period Fully Replicated Crossover With Multiple Groups [General Sta­tis­tics]

posted by Pankaj Bhangale – India, 2011-09-03 12:37 (5409 d 14:36 ago) – Posting: # 7332
Views: 7,172

Dear All,

Four period replicated crossover BE Study with 72 subjects. The subjects are divided in two groups with 36 Subject due to insufficient clinical capacity.

According to US-FDA Guidance for Industry, SAS code with ANOVA model to be used for the analysis of replicate crossover designs without groups is as follows.

proc mixed data=replicate;
class sequence period formulation subject;
model LCmax=sequence period formulation/ddfm=satterth;
random formulation/type=FA0(2) sub=subject G;
repeated/GRP=formulation sub=subject;
lsmeans formulation;
estimate 'Test vs Reference' formulation -1 1/CL alpha=0.10;
run;


Modified above SAS code with multiple groups is as follows:

proc mixed data=replicate;
class sequence period group formulation subject;
model LCmax=sequence period formulation group/ddfm=satterth;
random formulation/type=FA0(2) sub=subject G;
repeated/GRP=formulation sub=subject;
lsmeans formulation;
estimate 'Test vs Reference' formulation -1 1/CL alpha=0.10;
run;


Is it correct SAS code with ANOVA model for the analysis of replicate designs with multiple groups?

Regards,
Pankaj Bhangale

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
159 visitors (0 registered, 159 guests [including 23 identified bots]).
Forum time: 03:14 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5